Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

This study has been completed.

Study NCT00004373 Information provided by Office of Rare Diseases (ORD)

First Received: October 18, 1999 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2001
Estimated Primary Completion Date:	No date given